Kenox and Lactiga Partner to Advance Mucosal-Targeted Immunotherapy
March 10, 2025
Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory IgA (sIgA)